Clinical trial
Evaluation of the Impact of the Update Multiple Myeloma Criteria on the Natural History of Smoldering Myeloma in Order to Establish New Recommendations About Follow-up and Prognostic Evaluation of Smoldering Myeloma (CARRISMM)
NCT04144387 is registered in ClinicalTrials.gov with Intergroupe Francophone du Myelome as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Impact of the Update Multiple Myeloma Criteria on the Natural History of Smoldering Myeloma in Order to Establish New Recommendations About Follow-up and Prognostic Evaluation of Smoldering Myeloma (CARRISMM)
- Lead sponsor
- Intergroupe Francophone du Myelome
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- February 11, 2020
- Completion date
- December 31, 2028
- Enrollment
- 395 (actual)
- Sites
- 90
Conditions
As the registry lists them; a condition with its own page is linked.